{"id":"5c05e0a6-e149-5b55-84ee-88c155db546c","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-oct1-variants-response","predicate":"reduces","statement":"In clinical studies the effects of metformin in glucose tolerance tests were significantly smaller in people carrying reduced-function OCT1 polymorphisms.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"82228cef-6c33-5183-a1e9-90e45e80577d","mechanism_event_label":"People who carry a weaker version of the transporter responded less to the drug.","subject":{"id":"ed5c2568-3639-586f-9d50-9183576f44fb","slug":"oct1-reduced-function-variants","display_name":"Human OCT1 reduced-function coding variants in the 2007 and 2015 studies","entity_type_key":"protein_set"},"object":{"id":"e4efb34e-ff1b-5f72-aacc-601c0e6ebafa","slug":"serum-glucose-concentration","display_name":"Serum glucose concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"82228cef-6c33-5183-a1e9-90e45e80577d","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-oct1-variants-response-event","event_type":"observed_intervention","label":"People who carry a weaker version of the transporter responded less to the drug.","description":"In clinical studies the effects of metformin in glucose tolerance tests were significantly smaller in people carrying reduced-function OCT1 polymorphisms.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"3cced77c-b044-5d97-8c81-4ff9ed3dd169","slug":"slc22a1","display_name":"Human organic cation transporter 1 / OCT1 / SLC22A1","entity_type_key":"protein"},"role":"affected_transporter","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"ed5c2568-3639-586f-9d50-9183576f44fb","slug":"oct1-reduced-function-variants","display_name":"Human OCT1 reduced-function coding variants in the 2007 and 2015 studies","entity_type_key":"protein_set"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"e4efb34e-ff1b-5f72-aacc-601c0e6ebafa","slug":"serum-glucose-concentration","display_name":"Serum glucose concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/metformin-research/17476361.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1\", \"start_char\": 0, \"end_char\": 1361, \"text_sha256\": \"e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Metformin in Oct1-deficient mice; seven non-synonymous human OCT1 variants; clinical glucose tolerance tests","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Pharmacogenetic association with drug response, not proof that OCT1 genotype should guide prescribing.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"metformin","display_name":"Metformin","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Mouse and human, stated per record","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"People who carry a weaker version of the transporter responded less to the drug.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Hepatocytes and whole body","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"8d5f89e2-e3ec-5ec2-8dca-e310e4a66cd8","evidence_kind":"source_excerpt","locator":"Lines 164-175","start_line":164,"end_line":175,"excerpt":"### metformin-oct1-variants-response\nIn clinical studies the effects of metformin in glucose tolerance tests were significantly smaller in people carrying reduced-function OCT1 polymorphisms.\nCondition category: machinery_impairment\nnutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.\nplain_language: People who carry a weaker version of the transporter responded less to the drug.\norganism: Mouse and human, stated per record\ntissue_or_cell_type: Hepatocytes and whole body\nexperimental_model: Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies\nlimitations: Pharmacogenetic association with drug response, not proof that OCT1 genotype should guide prescribing.\nexposure: Metformin in Oct1-deficient mice; seven non-synonymous human OCT1 variants; clinical glucose tolerance tests\nevidence_span: {\"source_cache\": \"artifacts/metformin-research/17476361.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1\", \"start_char\": 0, \"end_char\": 1361, \"text_sha256\": \"e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1\"}\n[metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558","model_system":"Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d0474bd9-7cfd-5695-a152-12f3633a6813","stable_key":"import-8b3cf083-ea9c-54f5-b42b-bf1fef5b2978","title":"Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"0b51d0759aeeb88ac5b3a6277245a196b2bb024d7c32ec89379ed428fb06bfb5","revision_id":"0405c75e-f06e-5af7-a642-1777802f6004","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}